Inova Health System Strategic Investments
A veteran med-tech CEO, Michael Thomas is venture capital investor with the Inova Health System Strategic Investments team (ISI and IPHA).
Prior to Inova, Michael was CEO of Appian Partners, an Annapolis, MD-based life sciences consulting practice. His med-tech experience spanned several early stage, growth stage, and turn-around ventures as CEO of Appian Partners, ReGear Life Sciences, NuSomnea, Tanzen Medical, Appian Medical, iSonea, and Sleep Solutions. Mr. Thomas was founder and CEO of Appian Medical, a digital health firm that developed an algorithm to diagnose Obstructive Sleep Apnea. Mr. Thomas spent 2.5 years as CEO of iSonea Ltd (ASX:ISN), a publicly traded global, asthma digital healthcare company. He raised $25MM for iSonea and increased the company’s market capitalization from $4MM to $250MM. He is a member of the Board of Directors for Circadiance, a specialty CPAP mask manufacturer.
Earlier in his career, Thomas was CEO of Sleep Solutions, a VC-¬‐backed medical device manufacturer. He raised over $50 million in VC funding. Prior to joining Sleep Solutions, Thomas was EVP of Sales and Marketing for National Sleep Technologies (NST), where he led acquisitions of more than 80 sleep labs, making NST the largest sleep testing company in the US. NST was later sold to GE Medical. Earlier in his career, Thomas was Vice President of Sales at Patient InfoSystems (NASDAQ: PATI) and instrumental in taking that company public while delivering an 80 X return to shareholders.
He began his career in sales and marketing at Merck and Glaxo. Thomas graduated from Cornell University with a degree in Microbiology.
Michael is attending / has attended: